tooltip layer (initially hidden)
introduction browse basic search advanced search author application
Protein A003972
Author-entered Data
V1.0, Peer Reviewed
Published 22 Aug 2007
Automated Data
Not Reviewed
As At Publication
Automated Data
Not Reviewed
Latest from 10 Aug 2010

UCSD-Nature Molecule Pages
Published online: 22 Aug 2007 | doi:10.1038/mp.a003972.01

Matriptase

Thomas H Bugge1, Roman Szabo2

1Proteases and Tissue Remodeling Unit, National Institute of Dental and Craniofacial Research, MD 20892, US. 2National Institutes of Health, MD 20892, US.

Correspondence should be addressed to Thomas H Bugge: thomas.bugge@nih.gov


Matriptase (MT-SP1, TADG-15, epithin, ST14, PRSS14) is an 80- to 90-kDa trypsin-like, multi-domain type II transmembrane serine protease. Matriptase is an endopeptidase that hydrolyses peptide bonds after arginine or lysine residues. These cleavage reactions, which take place on the cell surface, activate specific growth factors, G-protein-coupled receptors and other proteolytic enzymes. The cytoplasmic tail of matriptase is anchored to the actin cytoskeleton by filamin. Matriptase cleaves and activates protease activated receptor-2, pro-urokinase plasminogen activator, pro-hepatocyte growth factor, subtractive immunization M+ HEp3-associated 135 kDa protein (SIMA-135)/cub domain containing protein-1 (CDCP-1)/transmembrane and associated with Src kinases (Trask), and pro-prostasin. Matriptase is inhibited by insertion of the reactive site loop of Kunitz domain one of the hepatocyte growth factor activator inhibitor-1 (HAI-1), a Kunitz-type transmembrane serine protease inhibitor. The extracellular ectodomains of the matriptase/HAI-1 complex are then proteolytically shed from the cell surface.

Alternative names for this molecule: Epithin; HAI; Matriptase; matriptase; matriptase/MT-SP1; membrane-type serine protease; MT-SP1; MTSP-1; MTSP1; protease, serine, 14 (epithin); Prss14; serine protease TADG-15; SNC19; St14; suppression of tumorigenicity 14; suppression of tumorigenicity 14 (colon carcinoma); suppression of tumorigenicity 14 (colon carcinoma, matriptase, epithin); TADG-15; tumor associated differentially expressed gene 15 protein

Transition Network Graph This molecule exists in 10 states, has 10 transitions between these states and has 5 enzyme functions.

[map] View high resolution network map

Acknowledgments: We thank Drs. Silvio Gutkind and Mary Jo Danton for critically reviewing this manuscript. This work was supported by the NIH Intramural program and by a grant from the Department of Defense (DAMD-17-02-1-0693) to Dr. Thomas H. Bugge.

 

HOME | SIGNALING UPDATE | MOLECULE PAGES | DATA CENTER | ABOUT US
registration | e-alert | help | contact us | site guide | search
Permitted Use of Material

Privacy Policy